RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Capricor Therapeutics Stocks 2024

Capricor Therapeutics Stocks

26.78 M

Capricor Therapeutics Dividend yield

Ticker

CAPR

ISIN

US14070B3096

WKN

A2PLU4

In 2024, Capricor Therapeutics had 26.78 M outstanding stocks, a 0% change from the 26.78 M stocks in the previous year.

The Capricor Therapeutics Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e26.78
2028e26.78
2027e26.78
2026e26.78
2025e26.78
2024e26.78
202326.78
202224.55
202123.09
202015.57
20193.71
20182.94
20172.68
20161.86
20151.59
20141.17
20131.05
20120.99
20110.07
20100.06
20090.05
20080.05
20070.03
20060.03
20050.02
20040.02

Capricor Therapeutics Aktienanalyse

What does Capricor Therapeutics do?

Capricor Therapeutics Inc is a leading biotechnology company specializing in the development of regenerative medications and therapies to treat serious illnesses. It was founded in 2005 and is headquartered in Los Angeles, California. Capricor Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Capricor Therapeutics's Shares Outstanding

Capricor Therapeutics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Capricor Therapeutics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Capricor Therapeutics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Capricor Therapeutics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Capricor Therapeutics Stock

How many stocks are there of Capricor Therapeutics?

The current number of stocks of Capricor Therapeutics is 26.78 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Capricor Therapeutics are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Capricor Therapeutics evolved in recent years?

The number of shares of Capricor Therapeutics has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Capricor Therapeutics as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Capricor Therapeutics?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Capricor Therapeutics pay?

Over the past 12 months, Capricor Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Capricor Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Capricor Therapeutics?

The current dividend yield of Capricor Therapeutics is .

When does Capricor Therapeutics pay dividends?

Capricor Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Capricor Therapeutics?

Capricor Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Capricor Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Capricor Therapeutics located?

Capricor Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Capricor Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Capricor Therapeutics from 5/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/21/2024.

When did Capricor Therapeutics pay the last dividend?

The last dividend was paid out on 5/21/2024.

What was the dividend of Capricor Therapeutics in the year 2023?

In the year 2023, Capricor Therapeutics distributed 0 USD as dividends.

In which currency does Capricor Therapeutics pay out the dividend?

The dividends of Capricor Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Capricor Therapeutics

Our stock analysis for Capricor Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Capricor Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.